The Cancer Research Cener of the Albert Einstein College of Medicine, established in 1972, now consists of 51 investigators individually funded for cancer research. Their research programs fall into 7 major and overlapping areas: 1) carcinogenic and chemotherapeutic agents, 2) immunooncology, 3) nucleic acid synthesis and viral oncology, 4) membrane synthesis, structure and function in normal and malignant cells, 5) gene expression in malignant cells, 6) cell structure, function and regulation, and 7) clinical studies. In 1975, the Center received a NCI award toward the construction of a new Cancer Research Facility. Originally scheduled for completion in the summer of 1978, this was occupied in January, 1979 and currently houses 24 of the 51 investigators of the Center, as well as a broad spectrum of shared services and facilities, including an animal facility; facilities for the breeding of """"""""nude"""""""" mice; a biohazard facility to accommodate experiments at the P2 and P3 level, as well as experimental animals inoculated with biohazardous agents; support facilities for cell culture; a fluorescent cell sorter; an analytical ultrastructure center; glasswashing facilities; a research library; and common equipment areas. The current Center Core Grant is a five-year grant with committed support until May 31, 1981 (year - 10). The current annual budget provides partial salary support for cancer investigators; developmental (2-year) seed support for incoming new investigators; support for research associates (12) and research assistants (4-6); partial support of a clinical research program; partial support also of a broad spectrum of shared services and facilities; and administrative support for the entire research program. The present application is a request for the renewal of this Center Core Grant for an additional five-year period at approximately its present level, with the addition of a Nuclear Magnetic Resonance facility to be shared by all the cancer investigators, and 4 new items of shared equipment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013330-19
Application #
3101327
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1977-06-01
Project End
1991-05-31
Budget Start
1990-06-01
Budget End
1991-05-31
Support Year
19
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Bines, Jose; Tevaarwerk, Amye J (2018) Baby steps: Pregnancy outcomes after human epidermal growth factor receptor 2-targeted therapy. Cancer :
Mathew, Deepti; Wang, Yanhua; Van Arsdale, Anne et al. (2018) Expression of ?V-Tubulin in Secretory Cells of the Fallopian Tube Epithelium Marks Cellular Atypia. Int J Gynecol Cancer 28:363-370
Mao, Kai; Quipildor, Gabriela Farias; Tabrizian, Tahmineh et al. (2018) Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice. Nat Commun 9:2394
Entenberg, David; Voiculescu, Sonia; Guo, Peng et al. (2018) A permanent window for the murine lung enables high-resolution imaging of cancer metastasis. Nat Methods 15:73-80
Iqbal, Niloy Jafar; Lu, Zhonglei; Liu, Shun Mei et al. (2018) Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity. JCI Insight 3:
Sharma, Yogeshwar; Liu, Jinghua; Kristian, Kathleen E et al. (2018) In Atp7b-/- Mice Modeling Wilson's Disease Liver Repopulation with Bone Marrowderived Myofibroblasts or Inflammatory Cells and not Hepatocytes is Deleterious. Gene Expr :
De Martino, Daniela; Yilmaz, Emrullah; Orlacchio, Arturo et al. (2018) PI3K blockage synergizes with PLK1 inhibition preventing endoreduplication and enhancing apoptosis in anaplastic thyroid cancer. Cancer Lett 439:56-65
Norwood Toro, Laura E; Wang, Yarong; Condeelis, John S et al. (2018) Myosin-IIA heavy chain phosphorylation on S1943 regulates tumor metastasis. Exp Cell Res 370:273-282
Agalliu, Ilir; Chen, Zigui; Wang, Tao et al. (2018) Oral Alpha, Beta, and Gamma HPV Types and Risk of Incident Esophageal Cancer. Cancer Epidemiol Biomarkers Prev 27:1168-1175
Bhargava, Ragini; Sandhu, Manbir; Muk, Sanychen et al. (2018) C-NHEJ without indels is robust and requires synergistic function of distinct XLF domains. Nat Commun 9:2484

Showing the most recent 10 out of 1508 publications